-transparent.png){kind=logo}
Subclavian vein cannulation, although a major progress in temporary vascular access, was associated with a significant morbidity and mortality. A safer alternative technique would therefore be welcome. For the last 2 years, we developed a new approach consisting in internal jugular vein cannulation (IJVC) with 2 silicone rubber catheters with a long-term proved biocompatibility. 138 pairs of cannulae were inserted in 129 uremics patients. Mean duration of use was 54 days (1 day to 17 months). More than 3,000 high-performance HD sessions were performed. IJVC handling and care was easily managed by nurses. Low incidence of complications was observed: 2 thrombosis episodes, 3 skin infection with 2 septicemiae, 1 air embolism, 1 anaphylactoid reaction. No death was related to the technique itself. IJVC offers a new method of percutaneous central vein cannulation, providing a safe and reliable temporary vascular access immediately usable for all kinds of extracorporeal treatment.
B Canaud, and
J J Beraud, and
H Joyeux, and
C Mion
January 1986,
Nephrologie,
B Canaud, and
J J Beraud, and
H Joyeux, and
C Mion
April 1977,
Surgery, gynecology & obstetrics,
B Canaud, and
J J Beraud, and
H Joyeux, and
C Mion
April 2002,
Journal of cardiothoracic and vascular anesthesia,
B Canaud, and
J J Beraud, and
H Joyeux, and
C Mion
November 1987,
The British journal of surgery,
B Canaud, and
J J Beraud, and
H Joyeux, and
C Mion
May 1978,
American journal of surgery,
B Canaud, and
J J Beraud, and
H Joyeux, and
C Mion
May 1987,
Canadian journal of surgery. Journal canadien de chirurgie,
B Canaud, and
J J Beraud, and
H Joyeux, and
C Mion
May 1992,
The International journal of artificial organs,
B Canaud, and
J J Beraud, and
H Joyeux, and
C Mion
January 1988,
Nephron,
B Canaud, and
J J Beraud, and
H Joyeux, and
C Mion
January 1986,
NITA,
B Canaud, and
J J Beraud, and
H Joyeux, and
C Mion
January 1998,
Nephron,
